Detalhe da pesquisa
1.
Physiologically-Based Pharmacokinetic Modeling of Remdesivir and Its Metabolites to Support Dose Selection for the Treatment of Pediatric Patients With COVID-19.
Clin Pharmacol Ther
; 109(4): 1116-1124, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33501997
2.
Brief Report: Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials.
J Acquir Immune Defic Syndr
; 88(4): 393-398, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34506342
3.
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trial.
Lancet Child Adolesc Health
; 5(9): 642-651, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34302760
4.
Compassionate Use of Remdesivir in Children With Severe COVID-19.
Pediatrics
; 147(5)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33883243
5.
Pharmacokinetics and Pharmacodynamics of Atazanavir in HIV-1-Infected Children Treated With Atazanavir Powder and Ritonavir: Combined Analysis of the PRINCE-1 and -2 Studies.
Pediatr Infect Dis J
; 37(6): e157-e165, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29206748
6.
Safety and Efficacy of Atazanavir Powder and Ritonavir in HIV-1-Infected Infants and Children From 3 Months to <11 Years of Age: The PRINCE-2 Study.
Pediatr Infect Dis J
; 37(6): e149-e156, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29206747
7.
Safety, efficacy, and pharmacokinetics of single-tablet elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed, HIV-infected children: a single-arm, open-label trial.
Lancet Child Adolesc Health
; 1(1): 27-34, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30169223
8.
Infections in patients with Shwachman-Diamond syndrome.
Pediatr Infect Dis J
; 24(2): 179-81, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15702050
9.
Glycosylation of the ENV spike of primate immunodeficiency viruses and antibody neutralization.
Curr HIV Res
; 2(3): 243-54, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15279588
10.
Determining an optimal testing strategy for infants at risk for mother-to-child transmission of HIV-1 during the late postnatal period.
AIDS
; 22(17): 2341-6, 2008 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-18981773
11.
p6gag of human and simian immunodeficiency viruses is tolerant to small in-frame deletions downstream of the late domain.
Virology
; 346(2): 479-89, 2006 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16332383
12.
Identification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4.
J Virol
; 79(19): 12575-83, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16160185